Guidelines for measuring impacts of methamphetamine precursor chemical regulations: A reply to Reuter and Caulkins (2003)

Addiction

Volumn 98, Issue 10, 2003, Pages 1463-1464

  Cunningham, James K ^a   Liu, Lon Mu ^b  

^a Public Statistics Institute   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

BIOAVAILABILITY; DRUG USE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LETTER; MEDICAL RESEARCH; PRECURSOR; REDUCTION; REGULATORY MECHANISM;

CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG AND NARCOTIC CONTROL; EPHEDRINE; HUMANS; LEGISLATION, DRUG; METHAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 0142061658     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2003.00539.x     Document Type: Letter

References (4)

1. Cunningham, J. K. & Liu, L.-M. (2003) Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. Addiction, 98, 000-000.
2. Edwards, G. (2001) Time-series analysis as an important contemporary statistical tool. Addiction, 96, 941-942.
3. Liu, L-M. & Chen, C. (1991) Recent developments of time series analysis in intervention and environmental impact studies. Journal of Environmental Science and Health, A26, 1217-1252.
4. Reuter, P. & Caulkins, J. P. (2003) Does precursor regulation make a difference? Addiction, 98, 1177-1179.